URTICARIA
Clinical trials for URTICARIA explained in plain language.
Never miss a new study
Get alerted when new URTICARIA trials appear
Sign up with your email to follow new studies for URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI boosts skin diagnosis accuracy for family doctors
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) tool could help primary care doctors more accurately diagnose skin conditions like melanoma, psoriasis, and eczema. Nine doctors reviewed 30 skin images, first diagnosing on their own and then with the AI's suggestions. Th…
Matched conditions: URTICARIA
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Jun 17, 2026 05:40 UTC
-
AI boosts skin diagnosis accuracy in new study
Diagnosis CompletedThis study tested whether an artificial intelligence (AI) device can help doctors more accurately diagnose a wide range of skin conditions, from rashes to skin cancer. Sixteen doctors (10 general practitioners and 6 dermatologists) reviewed 29 skin images, first giving a diagnosi…
Matched conditions: URTICARIA
Sponsor: AI Labs Group S.L • Aim: Diagnosis
Last updated Jun 03, 2026 12:05 UTC
-
Nasal spray may offer fast hives relief without needles
Symptom relief CompletedThis study tested a single dose of a nasal spray called ARS-1 (intranasal epinephrine) in 21 adults who get frequent hives and itching. The goal was to see if the spray works faster and better than a placebo at reducing itch and hive scores during flare-ups. Participants were mon…
Matched conditions: URTICARIA
Phase: PHASE2 • Sponsor: ARS Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 16, 2026 12:50 UTC
-
ER hives study: antihistamine alone may be enough
Symptom relief CompletedThis study looked at whether a single antihistamine works as well as antihistamine plus steroids for treating sudden hives in the emergency department. 137 adults with acute hives (with or without mild swelling) took part. The goal was to see if adding steroids is necessary for s…
Matched conditions: URTICARIA
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 15, 2026 19:05 UTC
-
New tablet shows promise for chronic hives in small study
Symptom relief CompletedThis study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives (urticaria). Participants took one tablet before a main meal for 28 days. The results showed better control of hives and improved quality of life, with no major safety concerns.
Matched conditions: URTICARIA
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jun 05, 2026 12:08 UTC
-
New pill shows promise for stubborn hives in early trial
Symptom relief CompletedThis study tested a new drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching) that standard treatments couldn't control. Participants took the drug or a placebo for 12 weeks to see if it reduced their hive and itch scores. The goal was to f…
Matched conditions: URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated Jun 01, 2026 18:05 UTC